Cargando…
Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation
BACKGROUND: Enlargement of left atrial (LA) size indicates advanced disease stage in patients with atrial fibrillation (AF) and is associated with poor success of different AF therapies. Two dimensional echocardiographic LA measurements do not reliably reflect the true size of LA anatomy. The aim of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404891/ https://www.ncbi.nlm.nih.gov/pubmed/30371296 http://dx.doi.org/10.1161/JAHA.118.009427 |
_version_ | 1783400973807386624 |
---|---|
author | Seewöster, Timm Büttner, Petra Nedios, Sotirios Sommer, Philipp Dagres, Nikolaos Schumacher, Katja Bollmann, Andreas Hilbert, Sebastian Jahnke, Cosima Paetsch, Ingo Hindricks, Gerhard Kornej, Jelena |
author_facet | Seewöster, Timm Büttner, Petra Nedios, Sotirios Sommer, Philipp Dagres, Nikolaos Schumacher, Katja Bollmann, Andreas Hilbert, Sebastian Jahnke, Cosima Paetsch, Ingo Hindricks, Gerhard Kornej, Jelena |
author_sort | Seewöster, Timm |
collection | PubMed |
description | BACKGROUND: Enlargement of left atrial (LA) size indicates advanced disease stage in patients with atrial fibrillation (AF) and is associated with poor success of different AF therapies. Two dimensional echocardiographic LA measurements do not reliably reflect the true size of LA anatomy. The aim of the current study was: 1) to analyze cardiovascular magnetic resonance (CMR)‐derived LA dimensions and their association with low voltage areas (LVA); and 2) to investigate the association between these parameters and NT‐proANP (N‐terminal proatrial natriuretic peptide) levels. METHODS AND RESULTS: Patients undergoing first AF catheter ablation were included. All patients underwent CMR imaging (Ingenia 1.5T Philips) before intervention. CMR data (LA volume, superior–inferior, transversal and anterior–posterior LA diameters) were measured in all patients. LVA were determined using high‐density maps and a low voltage threshold <0.5 mV. Blood plasma samples from femoral vein were collected before catheter ablation. NT‐proANP levels were studied using commercially available assays. There were 216 patients (65±11 years, 59% males, 56% persistent AF, 26% LVA) included into analyses. NT‐proANP levels in patients with LVA were significantly higher than in those without (median/interquartile range 22 [13–29] versus 15 [9–22] pg/mL, P=0.004). All CMR derived LA diameters correlated significantly with persistent AF (r²=0.291–0.468, all P<0.001), LVA (r²=0.187–0.306, all P<0.001), and NT‐proANP levels (r²=0.258–0.352, P<0.01). On logistic regression multivariable analysis, age (odds ratio=1.090, 95% confidence interval: 1.030–1.153, P=0.003), females (odds ratio=2.686, 95% confidence interval: 1.047–6.891, P=0.040), and LA volume (odds ratio=1.022, 95% confidence interval: 1.009–1.035, P=0.001) remained significant predictors for LVA. CONCLUSIONS: Left atrial CMR parameters are associated with persistent AF, low voltage areas and NT‐proANP levels. LA volume is the most significant predictor for LVA. |
format | Online Article Text |
id | pubmed-6404891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64048912019-03-19 Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation Seewöster, Timm Büttner, Petra Nedios, Sotirios Sommer, Philipp Dagres, Nikolaos Schumacher, Katja Bollmann, Andreas Hilbert, Sebastian Jahnke, Cosima Paetsch, Ingo Hindricks, Gerhard Kornej, Jelena J Am Heart Assoc Original Research BACKGROUND: Enlargement of left atrial (LA) size indicates advanced disease stage in patients with atrial fibrillation (AF) and is associated with poor success of different AF therapies. Two dimensional echocardiographic LA measurements do not reliably reflect the true size of LA anatomy. The aim of the current study was: 1) to analyze cardiovascular magnetic resonance (CMR)‐derived LA dimensions and their association with low voltage areas (LVA); and 2) to investigate the association between these parameters and NT‐proANP (N‐terminal proatrial natriuretic peptide) levels. METHODS AND RESULTS: Patients undergoing first AF catheter ablation were included. All patients underwent CMR imaging (Ingenia 1.5T Philips) before intervention. CMR data (LA volume, superior–inferior, transversal and anterior–posterior LA diameters) were measured in all patients. LVA were determined using high‐density maps and a low voltage threshold <0.5 mV. Blood plasma samples from femoral vein were collected before catheter ablation. NT‐proANP levels were studied using commercially available assays. There were 216 patients (65±11 years, 59% males, 56% persistent AF, 26% LVA) included into analyses. NT‐proANP levels in patients with LVA were significantly higher than in those without (median/interquartile range 22 [13–29] versus 15 [9–22] pg/mL, P=0.004). All CMR derived LA diameters correlated significantly with persistent AF (r²=0.291–0.468, all P<0.001), LVA (r²=0.187–0.306, all P<0.001), and NT‐proANP levels (r²=0.258–0.352, P<0.01). On logistic regression multivariable analysis, age (odds ratio=1.090, 95% confidence interval: 1.030–1.153, P=0.003), females (odds ratio=2.686, 95% confidence interval: 1.047–6.891, P=0.040), and LA volume (odds ratio=1.022, 95% confidence interval: 1.009–1.035, P=0.001) remained significant predictors for LVA. CONCLUSIONS: Left atrial CMR parameters are associated with persistent AF, low voltage areas and NT‐proANP levels. LA volume is the most significant predictor for LVA. John Wiley and Sons Inc. 2018-09-20 /pmc/articles/PMC6404891/ /pubmed/30371296 http://dx.doi.org/10.1161/JAHA.118.009427 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Seewöster, Timm Büttner, Petra Nedios, Sotirios Sommer, Philipp Dagres, Nikolaos Schumacher, Katja Bollmann, Andreas Hilbert, Sebastian Jahnke, Cosima Paetsch, Ingo Hindricks, Gerhard Kornej, Jelena Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation |
title | Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation |
title_full | Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation |
title_fullStr | Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation |
title_full_unstemmed | Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation |
title_short | Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation |
title_sort | association between cardiovascular magnetic resonance‐derived left atrial dimensions, electroanatomical substrate and nt‐proanp levels in atrial fibrillation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404891/ https://www.ncbi.nlm.nih.gov/pubmed/30371296 http://dx.doi.org/10.1161/JAHA.118.009427 |
work_keys_str_mv | AT seewostertimm associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT buttnerpetra associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT nediossotirios associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT sommerphilipp associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT dagresnikolaos associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT schumacherkatja associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT bollmannandreas associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT hilbertsebastian associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT jahnkecosima associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT paetschingo associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT hindricksgerhard associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation AT kornejjelena associationbetweencardiovascularmagneticresonancederivedleftatrialdimensionselectroanatomicalsubstrateandntproanplevelsinatrialfibrillation |